STAIR has been established not only to conduct the initial set of investigations that the investigators have outlined (goals of STAIR), but also to provide an ongoing resource for collaboration with other investigators around the world. We welcome the potential to utilize the STAIR resources to advance biomedical science in areas ranging from basic laboratory to clinical therapeutics to clinical epidemiology, and other aspects of patient-oriented clinical investigation.
If you are an investigator interested in partnering with STAIR, we ask that you initially contact the Administrative Director of STAIR, Jean-Baptiste Roullett, PhD, with a brief summary (one paragraph) of your proposal. If the proposal seems feasible, you will be asked to provide a more detailed protocol summary to the entire STAIR Steering Committee.
If you are a health care provider - physician, medical geneticist, genetic counselor - seeing patients with one of the STAIR diseases (Smith-Lemli-Opitz Syndrome, Sjögren-Larsson Syndrome, Mevalonate Kinase Deficiency (Hyperimmunoglobulinemia D Syndrome (HIDS), Mevalonic Aciduria), Cerebrotendinous, Xanthomatosis, Sitosterolemia, Succinic Semialdehyde Dehydrogenase Deficiency), make them aware of the research conducted by STAIR investigators, refer them to this web site or give them STAIR contact information.